MOXD1 and gastric cancer: The mRNA expression of MOXD1 in T3 and T4 patients was significantly greater than that in T1 and T2 patients (Figure 4e), the mRNA expression of MOXD1 in N2 and N3 patients was significantly higher than that in N0 and N1 (Figure 4f), and the mRNA expression of MOXD1 in stage III patients was the highest (Figure 4g), which indicated that MOXD1 was closely related to the progression of GC.